SELLAS Life Sciences Group Files 8-K on Security Holder Vote Matters
Ticker: SLS · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1390478
| Field | Detail |
|---|---|
| Company | Sellas Life Sciences Group, Inc. (SLS) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
SELLAS Life Sciences Group is holding a shareholder vote.
AI Summary
On June 17, 2025, SELLAS Life Sciences Group, Inc. filed an 8-K report indicating a submission of matters to a vote of security holders. The company, incorporated in Delaware with its principal office at 7 Times Square, New York, NY, previously operated under the names Galena Biopharma, Inc. and RXi Pharmaceuticals Corp.
Why It Matters
This filing signals that important corporate decisions requiring shareholder approval are being put forth by SELLAS Life Sciences Group, Inc.
Risk Assessment
Risk Level: low — The filing is a routine procedural report regarding a shareholder vote and does not disclose new financial or operational risks.
Key Players & Entities
- SELLAS Life Sciences Group, Inc. (company) — Registrant
- Galena Biopharma, Inc. (company) — Former Company Name
- RXi Pharmaceuticals Corp (company) — Former Company Name
- June 17, 2025 (date) — Date of earliest event reported
- 7 Times Square, Suite 2503 New York, NY 10036 (location) — Company Business Address
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report the submission of matters to a vote of security holders.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is June 17, 2025.
What are the former names of SELLAS Life Sciences Group, Inc. mentioned in the filing?
The filing mentions former names including Galena Biopharma, Inc. and RXi Pharmaceuticals Corp.
In which state is SELLAS Life Sciences Group, Inc. incorporated?
SELLAS Life Sciences Group, Inc. is incorporated in Delaware.
What is the business address of SELLAS Life Sciences Group, Inc.?
The business address is 7 Times Square, Suite 2503, New York, NY 10036.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding SELLAS Life Sciences Group, Inc. (SLS).